Back to search

University of Ioannina

Σχεδιασμός, σύνθεση και βιολογική αξιολόγηση έξυπνων θεραπευτικών και θεραγνωστικών μορίων στοχεύοντας τον καρκίνο

Abstract

dc:description

Cancer constitutes one of the leading causes of morbidity and mortality worldwide, at an increasing rate. According to the World Health Organization, cancer is considered the second fatal disease in the world, after cardiovascular diseases. The accumulation of genetic alterations disrupts homeostasis and leads to the formation of neoplastic cells (cancer cells) which have distinct functional characteristics that ensure the survival and development of neoplastic cells, which in turn result in a differentiated tumor microenvironment. The treatment of cancer lies in its valid diagnosis and subsequent effective therapy, usually through surgery, chemotherapy and radiation, or a combination of these. Based on the differences of the microenvironment between healthy and cancer cells (e.g. overexpression of enzymes), we developed multiple ‘bioactive platforms’ that can be utilized in various ways either for cancer therapy or for simultaneous cancer diagnosis and therapy. Based on these ‘platforms’ we synthesized novel therapeutic and theragnostic prodrugs (simultaneous therapy and diagnosis), which selectively target the microenvironment of cancer cells and release the toxic anticancer drugs. Towards this aim, the anticancer drugs gemcitabine, paclitaxel and SN-38 were exploited, which are highly toxic, rendering them ideal for the targeted approach utilized. Also, we synthesized various fluorescent compounds (e.g. NIR dyes that emit in near infrared region) that contributed to the effective diagnosis of the tumor microenvironment. In addition, we used groups that can interact with different stimuli of the cancer microenvironment (e.g. hypoxia, elevated enzyme and glutathione concentrations) and cores with built-in self-immolative linkers capable of releasing rapidly and selectively anticancer drugs within the cancer microenvironment. Finally, various molecules that target cancer cells such as D-biotin, TPP+ and the tumor-homing peptide D-Lys6-GnRH were utilized.Through various combinations of the aforementioned moieties, 9 therapeutic and 8 theragnostic prodrugs were successfully synthesized and characterized. All intermediates and final compounds (95 in total) were purified by appropriate techniques such as column chromatography and RP-HPLC, characterized by 1D/2D NMR spectroscopy, mass spectrometry, and studied regarding their photophysical properties when applicable (final theragnostic compounds). In addition, the final compounds were evaluated over time regarding their stability within a wide pH range and in human blood plasma, using specified HPLC methodologies (each HPLC method was sculpted specifically for each prodrug). Finally, all prodrugs were tested for their biological profile including measurement of their cytotoxicity against cancer cell lines, their response upon encountering a specific stimulus (e.g. hypoxia), and their exploration of endocytosis pathways by confocal microscopy. The efficiency of the reported 'bioactive platforms' has been verified through the appropriate biological evaluation.

Degree

thesis:*
Grantor dc:publisher
University of Ioannina
Year dc:date
2021

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Vrettos, Eirinaios
  • Βρέττος, Ειρηναίος

Subjects

dc:subject × 18

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/49778

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Vrettos, Eirinaios; Βρέττος, Ειρηναίος. Σχεδιασμός, σύνθεση και βιολογική αξιολόγηση έξυπνων θεραπευτικών και θεραγνωστικών μορίων στοχεύοντας τον καρκίνο. University of Ioannina, 2021. http://hdl.handle.net/10442/hedi/49778